HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis.

AbstractOBJECTIVE:
To determine whether peroxisome proliferator-activated receptor (PPAR) gamma ligands improve survival of patients with septic shock we treated a mouse model of sepsis [apolipoprotein (Apo) E) knockout mice] with pioglitazone, a PPAR-gamma ligand. ApoE knockout mice have a high mortality rate due to sepsis because the endotoxin is not cleared.
DESIGN AND SETTING:
Prospective study in a university laboratory.
SUBJECTS:
We assorted 87 male ApoE knockout mice and 60 wild-type C57/B6 mice randomly into three groups (sepsis, pretreatment, posttreatment).
INTERVENTIONS:
Cecal ligation and puncture (CLP) was carried out in the sepsis and treatment groups. Mice were injected with pioglitazone (5 mg/kg per day) on the day before CLP or 6 h after surgery.
MEASUREMENTS AND RESULTS:
Both pre- and post-CLP treatment with pioglitazone improved survival of ApoE knockout and wild-type mice. Serum levels of cytokines and chemokines and myeloperoxidase activity in lung and liver were suppressed in the pioglitazone-treated group. Pioglitazone also suppressed monocyte adhesion to vascular endothelium under flow conditions.
CONCLUSIONS:
Pioglitazone improved survival of ApoE knockout mice after onset of septic shock through suppression of inflammatory responses.
AuthorsGo Haraguchi, Hisanori Kosuge, Yasuhiro Maejima, Jun-Ichi Suzuki, Takasuke Imai, Masayuki Yoshida, Mitsuaki Isobe
JournalIntensive care medicine (Intensive Care Med) Vol. 34 Issue 7 Pg. 1304-12 (Jul 2008) ISSN: 0342-4642 [Print] United States
PMID18283431 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins E
  • Cytokines
  • Hypoglycemic Agents
  • Thiazolidinediones
  • Peroxidase
  • Pioglitazone
Topics
  • Animals
  • Apolipoproteins E (blood)
  • Cytokines (blood)
  • Enzyme-Linked Immunosorbent Assay
  • Hypoglycemic Agents (therapeutic use)
  • Inflammation (drug therapy)
  • Liver (drug effects, enzymology, pathology)
  • Lung (drug effects, enzymology, pathology)
  • Male
  • Mice
  • Mice, Knockout
  • Peroxidase (metabolism)
  • Pioglitazone
  • Sepsis (drug therapy, metabolism, mortality)
  • Thiazolidinediones (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: